PSMA ligands for PET imaging of prostate cancer
SM Schwarzenboeck, I Rauscher… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Targeting the prostate-specific membrane antigen (PSMA) with 68Ga-labeled and 18F-
labeled PET agents has become increasingly important in recent years. Imaging of …
labeled PET agents has become increasingly important in recent years. Imaging of …
PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
S Fanti, S Minozzi, P Castellucci, S Balduzzi… - European journal of …, 2016 - Springer
Purpose For the last decade PET and PET/CT with 11 C-choline have been proposed for the
evaluation of prostate cancer (PC), but the diagnostic performance of 11 C-choline PET/CT …
evaluation of prostate cancer (PC), but the diagnostic performance of 11 C-choline PET/CT …
Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients …
T Maurer, JE Gschwend, I Rauscher… - The Journal of …, 2016 - auajournals.org
Purpose: Current standard imaging techniques are insufficient to reliably detect lymph node
metastases in prostate cancer. Recently ligands of PSMA (prostate specific membrane …
metastases in prostate cancer. Recently ligands of PSMA (prostate specific membrane …
18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
C Nanni, L Zanoni, C Pultrone, R Schiavina… - European journal of …, 2016 - Springer
Purpose To compare the accuracy of 18 F-FACBC and 11 C-choline PET/CT in patients
radically treated for prostate cancer presenting with biochemical relapse. Methods This …
radically treated for prostate cancer presenting with biochemical relapse. Methods This …
PET/CT imaging in cancer: current applications and future directions
MD Farwell, DA Pryma, DA Mankoff - Cancer, 2014 - Wiley Online Library
Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …
[HTML][HTML] Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease
JD Evans, KR Jethwa, P Ost, S Williams… - Practical radiation …, 2018 - Elsevier
Prostate cancer–specific positron emission tomography (pcPET) has been shown to detect
sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower …
sites of disease recurrence at serum prostate-specific antigen (PSA) levels that are lower …
Update on 18F-fluciclovine PET for prostate cancer imaging
EE Parent, DM Schuster - Journal of Nuclear Medicine, 2018 - Soc Nuclear Med
PET is a functional imaging method that can exploit various aspects of tumor biology to
enable greater detection of prostate cancer than can be provided by morphologic imaging …
enable greater detection of prostate cancer than can be provided by morphologic imaging …
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
N Pandit-Taskar, JA O'Donoghue, V Beylergil… - European journal of …, 2014 - Springer
Purpose Given the bone tropism of prostate cancer, conventional imaging modalities poorly
identify or quantify metastatic disease. 89 Zr-huJ591 positron emission tomography (PET) …
identify or quantify metastatic disease. 89 Zr-huJ591 positron emission tomography (PET) …
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease
DM Schuster, C Nanni, S Fanti, S Oka… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (18F-FACBC) is a synthetic amino
acid analog PET radiotracer undergoing clinical trials for the evaluation of prostate and other …
acid analog PET radiotracer undergoing clinical trials for the evaluation of prostate and other …
18F-fluciclovine PET/CT for the detection of prostate cancer relapse: a comparison to 11C-choline PET/CT
C Nanni, R Schiavina, E Brunocilla… - Clinical nuclear …, 2015 - journals.lww.com
Purpose In recent years, a new PET compound (anti-3-18 F-FACBC or 18 F-fluciclovine)
was tested for the detection of prostate cancer relapse. Despite very promising results, only …
was tested for the detection of prostate cancer relapse. Despite very promising results, only …